Rituximab is being used for many kidney diseases and now in the post transplant world as well
A recent report in pediatric Nephrology journal discusses a pulmonary complication of the drug.
This first report of rituximab-associated, Cryptogenic Organising Pneumonia highlights the risk of pulmonary complications after treatment with B-cell depleting agents in solid organ transplant recipients.
http://www.ncbi.nlm.nih.gov/pubmed/20140460
http://www.ncbi.nlm.nih.gov/pubmed/19681063
https://www.pediatric-nephrology.com/daily-updates/2010/05/31/212-ralimore.html
Monday, June 7, 2010
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment